Bank of New York Mellon Corp - SECOND SIGHT MED PRODS INC ownership

Back to all holdings Add to watchlist

SECOND SIGHT MED PRODS INC's ticker is EYESW and the CUSIP is 81362J118. A total of 1 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2019$2,0000.0%10,7000.0%0.00%–
Q3 2019$2,0000.0%10,7000.0%0.00%–
Q2 2019$2,0000.0%10,7000.0%0.00%–
Q1 2019$2,000–10,700–0.00%–
 Download
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2020
NameSharesValueWeighting ↓
&PARTNERS 21,961$4,0000.01%
Glassman Wealth Services 19,954$4,0000.00%
Sigma Planning Corp 161,337$32,0000.00%
NOMURA HOLDINGS INC 19,176$4,0000.00%
BNP PARIBAS FINANCIAL MARKETS 446,256$89,251,0000.00%
Bank of New York Mellon Corp 10,700$2,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 312,881$63,0000.00%
MORGAN STANLEY 271$00.00%
Edge Wealth Management LLC 1,278$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders